2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC7019 | |||||||||||||||||||||||
Submitter : | Ms. Kathleen Hurley | Date & Time: | 03/06/2006 09:03:50 | |||||||||||||||||||||
Organization : | Ms. Kathleen Hurley | |||||||||||||||||||||||
Category : | Health Professional | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
If my board certified physician prescribes bio-identical hormone replacement therapy for any individual regardless of gender that is clinically required they should continue to have the right to prescribe these compounds. Enough already. | ||||||||||||||||||||||||